Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.
Published November 23, 2022 · Recall initiated: October 13, 2022
Summary
FDA records drug Class III recall D-0059-2023, published November 23, 2022 and initiated October 13, 2022. Recalling firm: Aadi Bioscience; Status: Terminated; Reported quantity: 2,333 vials; Lot: Lot# 6025701, Expiration Date: 31MAR2023, 100mg/vial, 50 ml single use vial, NDC 80803-153-50. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Stability Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if FYARRO has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FYARRO
- Manufacturer
- Aadi Bioscience
- Distributor
- Within the U.S Market - PA, AL, KY, TN
- Lot
- Lot# 6025701, Expiration Date: 31MAR2023, 100mg/vial, 50 ml single use vial, NDC 80803-153-50.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATimolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Imprimis Rx, Ledgewood, NJ.November 23, 2022
- FDAPhenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par PharmaceuticalNovember 23, 2022
- FDA0.9% Sodium Chloride Injection, USP, 100 mL flexible container bag, Rx Only, ICU Medical, Inc., Lake Forest,November 23, 2022
- FDALa Rosa Brand BluCrab Pasteurized Crabmeat (Jumbo, Lump, Claw) Peso Neto: 454g Can label art is the same forNovember 16, 2022
- FDAChicken Salad Sandwich Club 18 Inch Tray, Black tray with 16 pre-made sandwiches, UPC 2 9615 90000 0,November 16, 2022
- FDAHammond's Salted Caramel Cookies, NET WT. 5 OZ (142g), UPC 6 91355 89889 5, Manufactured for: Hammond'sNovember 16, 2022
Questions about this recall
Was Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA. recalled?
Yes. FDA published recall D-0059-2023 on November 23, 2022. Reported hazard: Failed Stability Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FYARRO.